The Clorox Company $CLX Shares Acquired by Prospera Financial Services Inc

Prospera Financial Services Inc increased its holdings in shares of The Clorox Company (NYSE:CLX) by 22.0% in the second quarter, Holdings Channel reports. The firm owned 5,522 shares of the company’s stock after acquiring an additional 994 shares during the period. Prospera Financial Services Inc’s holdings in Clorox were worth $664,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. New York State Common Retirement Fund increased its position in shares of Clorox by 4.5% in the first quarter. New York State Common Retirement Fund now owns 75,087 shares of the company’s stock worth $11,057,000 after acquiring an additional 3,200 shares in the last quarter. CWM LLC lifted its holdings in shares of Clorox by 19.7% during the 1st quarter. CWM LLC now owns 36,194 shares of the company’s stock valued at $5,330,000 after acquiring an additional 5,960 shares in the last quarter. Apollon Wealth Management LLC boosted its position in Clorox by 4.1% during the 1st quarter. Apollon Wealth Management LLC now owns 3,502 shares of the company’s stock worth $516,000 after purchasing an additional 138 shares during the period. OVERSEA CHINESE BANKING Corp Ltd acquired a new stake in Clorox in the 1st quarter valued at $369,000. Finally, Cullen Frost Bankers Inc. raised its position in Clorox by 3.5% in the first quarter. Cullen Frost Bankers Inc. now owns 45,396 shares of the company’s stock valued at $6,685,000 after purchasing an additional 1,519 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.63% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $128.00 to $121.00 and set a “hold” rating for the company in a research report on Tuesday, November 4th. Bank of America decreased their price target on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Citigroup decreased their price target on Clorox from $130.00 to $120.00 and set a “neutral” rating for the company in a report on Tuesday, November 4th. Morgan Stanley dropped their price objective on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Finally, The Goldman Sachs Group decreased their target price on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research note on Wednesday, October 1st. One research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $125.69.

Clorox Stock Performance

Shares of CLX opened at $104.20 on Friday. The firm has a market cap of $12.71 billion, a price-to-earnings ratio of 15.98, a PEG ratio of 0.92 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The business’s 50 day moving average is $118.14 and its two-hundred day moving average is $123.98. The Clorox Company has a 52-week low of $104.08 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business’s quarterly revenue was down 18.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date was Wednesday, October 22nd. Clorox’s dividend payout ratio is 77.86%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.